The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say ...

Early invasive management does not reduce the risk of hard clinical outcomes, such as mortality or MI, in women with ...

Seeing is believing. Patients shown proof of calcification adhered better to statins; those without CAC avoided overtreatment ...

A one-stop approach resulted in a new diagnosis of HF for 3% of the clinic’s visitors, who then were referred for timely ...

Procedural planning and attention to detail can help, but heart teams should be realistic about what lies ahead, experts say.

PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.

Though arterial thrombotic risk was higher with hormonal contraception use, the absolute excess risks were low.

A SCAI survey found high rates of spinal injury amid signs that careers could be longer with better prevention and management ...

The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.